Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from BTIG

What 19 Analyst Ratings Have To Say About Exact Sciences

19 analysts have shared their evaluations of Exact Sciences (NASDAQ:EXAS) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga

Here's How High MicroStrategy Stock Can Climb as Bitcoin Races to New Highs

In the past five years, MicroStrategy's massive exposure to Bitcoin has allowed share prices to surge over 2,000%. Can the tech stock continue to surge in 2025?

Barchart

Wall Street is Overlooking This Penny Stock, Says Analyst

This penny stock could surge up to 200%, according to one bull, who has high hopes for a pipeline drug ahead of trial data due out in 2025.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Outperforming Stocks to Buy With $500 Right Now

With a budget of around $500, investors can scoop up these three standout stock picks, which have outperformed the broader market in the past year.

Barchart

Should You Buy the Dip in CrowdStrike After the Massive Microsoft Outage?

Despite a significant drop in the shares from its recent high-profile IT glitch, CrowdStrike’s strong fundamentals and growth trajectory make it a potential buy. Don’t miss the chance to grab this dip.

Barchart

Here’s What to Make of Big-Money Moves on SoFi Stock

A notable development in SoFi stock sees Qatar’s fund selling its stake, while the CEO purchases approximately $797k worth of shares shortly after. These contrasting actions reflect varying outlooks on SoFi’s future prospects and its competitive positioning in the financial market.

Barchart

From Apple to Walmart: Stock Market Winners and Losers as Student Loan Payments Restart

As student loan repayments start back up this October, some stocks could benefit while others might be negatively impacted. Here's the list of winners and losers as the student loan moratorium ends.

Barchart

Read news from The Economist, FT, and more,
with one subscription

From $47 billion to $270 million—WeWork, the Adam Neumann brainchild, keeps crashing after a 'going concern' warning

"Flexible workspaces have a future in the office ecosystem, but WeWork, in its current state, may not," BTIG analysts wrote Wednesday.

Fortune

Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022

Upgrades

Benzinga

This High-Yielding Dividend REIT Is Downgraded, As 2 Year Treasury Yield Outpaces Average Corporate Dividend Yield

As the U.S. 2-Year Treasury Yield has remained inversely related to the U.S. 10-Year Treasury Yield for some time now, this has signaled concerns for many investors and economists, as historically this points to a recession ahead.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022

Upgrades

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 29, 2022

Upgrades

Benzinga

BTIG Maintains Buy Rating for D.R. Horton: Here's What You Need To Know

BTIG has decided to maintain its Buy rating of D.R. Horton (NYSE:DHI) and lower its price target from $126.00 to $104.00. Shares of D.R. Horton are trading down 2.62% over the last 24 hours, at $70.32 per share. A move to $104.00 would account for a 47.9% increase from the…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2022

Benzinga

Read Why BTIG Slashed Starbucks Price Target By 15%

BTIG analyst Peter Saleh reduced the price target on Starbucks Corp (NASDAQ:SBUX) to $110 from $130 and kept a buy rating on the shares. The revised price target implies a 37% upside. The analyst also cut his FY22 and FY23 earnings estimates after factoring in the uncertainty of unionization, the high probability of wage and…

Benzinga

BTIG Remains Bullish On CoreCard Despite Apple's Move To Bring Financial Service Offerings In-House

The news of Apple Inc (NASDAQ:AAPL) developing payment-processing technology to bring some of its financial-services offerings in-house triggered a meltdown in CoreCard Corp (NYSE:CCRD) share prices. However, BTIG analyst Mark Palmer views the pressure on CoreCard shares as vivid. He sees it as unlikely that Apple's move to bring more of its payment processing in-house would…

Benzinga

10 Biggest Price Target Changes For Tuesday

BTIG cut the price target on NeoGenomics, Inc. (NASDAQ: NEO) from $35 to $28. NeoGenomics shares fell 29.2% to $12.60 in pre-market trading.

Benzinga

Why Are LGI Homes Shares Trading Lower Today

BTIG analyst Carl Reichardt downgraded LGI Homes (NASDAQ:LGIH) to Sell from Neutral with a $98 price target, implying an 11% downside. Carl showed concern about the company’s reliance on single-family rental investors for delivery volume and the impact of higher rates on those customers. The analyst thinks that LGI has a higher demand risk profile…

Benzinga

Here's Why BTIG Is Bullish On Datadog

BTIG analyst Gray Powell initiated coverage of Datadog Inc (NASDAQ:DDOG) with a Buy rating and $175 price target (24.9% upside). Powell saw the observability market benefiting over the next few years as companies increasingly invest in digital transformation initiatives. Powell saw Datadog "winning across multiple product categories." Powell's checks indicate Datadog as the most innovative…

Benzinga

BTIG Upgraded Staar Surgical Stock - Read Why

BTIG upgraded Implantable lenses-focused Staar Surgical Company (NASDAQ: STAA) to Buy from Neutral with a $98 price target.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.